Startseite Subcutaneous regular insulin use for the management of diabetic ketoacidosis in resource limited setting
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Subcutaneous regular insulin use for the management of diabetic ketoacidosis in resource limited setting

  • Bereket F. Yismaw ORCID logo EMAIL logo und Tigist W. Leulseged ORCID logo
Veröffentlicht/Copyright: 25. September 2021

Abstract

Objectives

The standard recommendation of insulin therapy for patients with DKA is the administration of slow continuous intravenous (IV) regular insulin. Currently subcutaneous insulin is being recommended as an alternative treatment of DKA in mild and moderate cases in resource-limited settings. The purpose of this study was to assess the effectiveness and safety of six-hourly subcutaneous regular insulin use for the treatment of DKA among children with type one diabetes mellitus.

Methods

A retrospective cohort study was conducted among 224 DKA episodes which occurred in 161 children who were treated at St. Paul’s Hospital Millennium Medical College in Addis Ababa, Ethiopia, from November 2015 to November 2020.

Results

Majority (68.8%) of the episodes occurred in newly diagnosed cases. The median time for urinary ketones clearance was 24 h. DKA severity was found to be the only significant predictor of time to DKA resolution. Only 13 (5.8%) were treated at the pediatric intensive care unit (PICU), and 27 (12.1%) developed complications during management. No death or neurological complications observed.

Conclusions

The six-hourly subcutaneous regular insulin use was found to be safe and effective alternative to slow IV insulin infusion for the treatment of DKA in a non PICU setting. As it resulted in minimum morbidity and no mortality, we recommend its use in the treatment of DKA irrespective of its severity. It can also decrease the health care cost and patients’ inconvenience.


Corresponding author: Bereket F. Yismaw, MD, Associate Professor of Pediatrics Endocrinology and Diabetes, Department of Pediatrics, Saint Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia, Phone: +251911411077, E-mail:

Acknowledgments

The authors would like to thank St. Paul’s Hospital Millennium Medical College for facilitating the research work by granting IRB approval and availing the data needed for the research. We also would like to extend our great appreciation to the data collectors for their commitment and timely work.

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Not applicable.

  5. Ethical approval: The SPHMMC institutional review board approved the study protocol.

References

1. Fantahun, B. Prevalence of diabetic ketoacidosis in newly diagnosed diabetes mellitus pediatric patients in tikur Anbessa Specialized Hospital. Ethiop J Pediatr Child Heal 2008;IV:4–11.Suche in Google Scholar

2. Rosenbloom, AL, Hanas, R. Diabetic ketoacidosis (DKA): treatment guidelines. Clin Pediatr (Phila) 1996;35:261–6. https://doi.org/10.1177/000992289603500506.Suche in Google Scholar PubMed

3. Wolfsdorf, J, Craig, ME, Daneman, D, Dunger, D, Edge, J, Lee, W, et al.. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatr Diabetes 2009;10(12 Suppl):118–33. https://doi.org/10.1111/j.1399-5448.2009.00569.x.Suche in Google Scholar PubMed

4. Wolfsdorf, JI, Glaser, N, Agus, M, Fritsch, M, Hanas, R, Rewers, A, et al.. ISPAD Clinical Practice Consensus Guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Pediatr Diabetes 2018;19:155–77. https://doi.org/10.1111/pedi.12701.Suche in Google Scholar PubMed

5. Icks, A, Strassburger, K, Baechle, C, Rosenbauer, J, Giani, G, Beyer, P, et al.. Frequency and cost of diabetic ketoacidosis in Germany – study in 12 001 paediatric patients. Exp Clin Endocrinol Diabetes 2013;121:58–9. https://doi.org/10.1055/s-0032-1312639.Suche in Google Scholar PubMed

6. Umpierrez, GE, Kitabchi, AE. Diabetic ketoacidosis: risk factors and management strategies. Treat Endocrinol 2003;2:95–108. https://doi.org/10.2165/00024677-200302020-00003.Suche in Google Scholar PubMed

7. Jayashree, M, Singhi, S. Diabetic ketoacidosis: predictors of outcome in a pediatric intensive care unit of a developing country. Pediatr Crit Care Med 2004;5:427–33. https://doi.org/10.1097/01.pcc.0000137987.74235.5e.Suche in Google Scholar PubMed

8. Cooke, DW, Plotnick, L. Management of diabetic ketoacidosis in children and adolescents. Pediatr Rev 2008;29:431–6. https://doi.org/10.1542/pir.29-12-431.Suche in Google Scholar PubMed

9. Thuzar, M, Malabu, UH, Tisdell, B, Sangla, KS. Use of a standardised diabetic ketoacidosis management protocol improved clinical outcomes. Diabetes Res Clin Pract 2014;104:2–5. https://doi.org/10.1016/j.diabres.2014.01.016.Suche in Google Scholar PubMed

10. Cohen, M, Leibovitz, N, Shilo, S, Zuckerman-Levin, N, Shavit, I, Shehadeh, N. Subcutaneous regular insulin for the treatment of diabetic ketoacidosis in children. Pediatr Diabetes 2017;18:290–6. https://doi.org/10.1111/pedi.12380.Suche in Google Scholar PubMed

11. Wolfsdorf, J, Glaser, N, Sperling, MA. Diabetic ketoacidosis in infants, children, and adolescents: a consensus statement from the American Diabetes Association. Diabetes Care 2006;29:1150–9. https://doi.org/10.2337/dc06-9909.Suche in Google Scholar

12. Priyambada, L, Wolfsdorf, JI, Brink, SJ, Fritsch, M, Codner, E, Donaghue, KC, et al.. ISPAD Clinical Practice Consensus Guideline: diabetic ketoacidosis in the time of COVID-19 and resource-limited settings-role of subcutaneous insulin. Pediatr Diabetes 2020;21:1394–402. https://doi.org/10.1111/pedi.13118.Suche in Google Scholar PubMed

13. Kliegman, R, Geme, J. DKA clinical classification. In: Nelson textbook of pediatrics, 21st ed. Elsevier Inc.; 2020:11844 p.Suche in Google Scholar

14. Savoldelli, RD, Farhat, SCL, Manna, TD. Alternative management of diabetic ketoacidosis in a Brazilian pediatric emergency department. Diabetol Metab Syndrome 2010;2. https://doi.org/10.1186/1758-5996-2-41.Suche in Google Scholar PubMed PubMed Central

15. von Oettingen, JE, Rhodes, ET, Wolfsdorf, JI. Resolution of ketoacidosis in children with new onset diabetes: evaluation of various definitions. Diabetes Res Clin Pract 2018;135:76–84. https://doi.org/10.1016/j.diabres.2017.09.011.Suche in Google Scholar PubMed PubMed Central

16. Noyes, KJ, Crofton, P, Bath, LE, Holmes, A, Stark, L, Oxley, CD, et al.. Hydroxybutyrate near-patient testing to evaluate a new end-point for intravenous insulin therapy in the treatment of diabetic ketoacidosis in children. Pediatr Diabetes 2007;8:150–6. https://doi.org/10.1111/j.1399-5448.2007.00240.x.Suche in Google Scholar PubMed

17. Sivanandan, S, Sinha, A, Jain, V, Lodha, R. Management of diabetic ketoacidosis. Indian J Pediatr 2011;78:576–84. https://doi.org/10.1007/s12098-010-0294-8.Suche in Google Scholar PubMed

18. Vincent, M, Nobécourt, E. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies. Diabetes Metab 2013;39:299–305. https://doi.org/10.1016/j.diabet.2012.12.003.Suche in Google Scholar PubMed

19. Della Manna, T, Schvartsman, C, Steinmetz, L, Kuperman, H, Campos, PR, Setian, N, et al.. Subcutaneous use of a fast-acting. Diabetes Care 2005;28:1856–61. https://doi.org/10.2337/diacare.28.8.1856.Suche in Google Scholar PubMed

20. Zurita-Cruz, JN, Nishimura-Meguro, E, Villasís-Keever, MA, Hernández-Méndez, ME, Garrido-Magaña, E, Rivera-Hernández, ADJ. Influence of the informal primary caretaker on glycemic control among prepubertal pediatric patients with type 1 diabetes mellitus. J Pediatr 2017;93:136–41. https://doi.org/10.1016/j.jped.2016.06.008.Suche in Google Scholar PubMed

21. Haftu, H, Hailu, T, Medhaniye, A, Gtsadik, T. Assessment of pattern and treatment outcome of patients admitted to pediatric intensive care unit, Ayder Referral Hospital, Tigray, Ethiopia, 2015. BMC Res Notes 2018;11:11–6. https://doi.org/10.1186/s13104-018-3432-4.Suche in Google Scholar PubMed PubMed Central

22. Arora, S, Cheng, D, Wyler, B, Menchine, M. Prevalence of hypokalemia in ED patients with diabetic ketoacidosis. Am J Emerg Med 2012;30:481–4. https://doi.org/10.1016/j.ajem.2011.01.002.Suche in Google Scholar PubMed

23. Lawrence, SE, Cummings, EA, Gaboury, I, Daneman, D. Population-based study of incidence and risk factors for cerebral edema in pediatric diabetic ketoacidosis. J Pediatr 2005;146:688–92. https://doi.org/10.1016/j.jpeds.2004.12.041.Suche in Google Scholar PubMed

24. Patel, A, Singh, D, Bhatt, P, Thakkar, B, Akingbola, OA, Srivastav, SK. Incidence, trends, and outcomes of cerebral edema among children with diabetic ketoacidosis in the United States. Clin Pediatr (Phila) 2016;55:943–51. https://doi.org/10.1177/0009922815617975.Suche in Google Scholar PubMed

Received: 2021-08-11
Accepted: 2021-09-13
Published Online: 2021-09-25
Published in Print: 2022-02-23

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Obesity after the Covid-19 pandemic and beyond
  4. Review Article
  5. Clinical profile and management challenges of disorders of sex development in Africa: a systematic review
  6. Original Articles
  7. Development and validation of a mobile application for point of care evaluation of growth failure
  8. Children-Dietary Inflammatory Index (C-DII), cardiometabolic risk, and inflammation in adolescents: a cross-sectional study
  9. Accelerated pubertal onset in short children with delayed bone age
  10. Screening for hypophosphatasia: does biochemistry lead the way?
  11. Subcutaneous regular insulin use for the management of diabetic ketoacidosis in resource limited setting
  12. NPR2 gene variants in familial short stature: a single-center study
  13. The effect of the COVID-19 pandemic on metabolic control in children with type 1 diabetes: a single-center experience
  14. Evaluating a standardized protocol for the management of diabetes insipidus in pediatric neurosurgical patients
  15. Development and assessment of a low-health-literacy, pictographic adrenal insufficiency action plan
  16. Effect of insulin resistance on lung function in asthmatic children
  17. A major health problem facing immigrant children: nutritional rickets
  18. Clinical profile, etiology, and diagnostic challenges of primary adrenal insufficiency in Sudanese children: 14-years’ experience from a resource limited setting
  19. Non-inferiority of liquid thyroxine in comparison to tablets formulation in the treatment of children with congenital hypothyroidism
  20. Short Communication
  21. Increased frequency of idiopathic central precocious puberty in girls during the COVID-19 pandemic: preliminary results of a tertiary center study
  22. Case Reports
  23. Gordon syndrome caused by a CUL3 mutation in a patient with short stature in Korea: a case report
  24. Nitisinone treatment during two pregnancies and breastfeeding in a woman with tyrosinemia type 1 – a case report
  25. Myxedema crisis and ovarian hyperstimulation in a child with Down syndrome
  26. First successful concomitant therapy of immune tolerance induction therapy and desensitization in a CRIM-negative infantile Pompe patient
Heruntergeladen am 28.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2021-0527/html
Button zum nach oben scrollen